News

In 2019, 262 million people worldwide had asthma, with 455,000 deaths from the chronic condition1, stark figures that highlight asthma control still needs improvement. Most people living with asthma believe that no physical symptoms mean their asthma is controlled, but...

Over 28 million people in the United States (US) have asthma1,2, with the condition named as the leading chronic disease in children, affecting approximately 4.9 million under the age of 182,3. In the US, asthma is one of the most...

Embedding compassion into policies, practices and everyday actions. Bedfont® Scientific Ltd. is a world leader in breath analysis, with over 49 years of expertise in designing and manufacturing medical devices. The innovative med-tech company, based in Harrietsham, was proud to...

Written by Dr Jafar Jafari, GI Cognition This article reflects the opinions of a healthcare professional. The views expressed are their own. The intended use for the GastroCH4ECK® is to aid in the diagnosis of the following disorders: Lactose Intolerance,...

Shortlisting recognises Bedfont’s role in driving innovation and technology leadership across Kent. Scott Deamer-Smith, Chief Technology Officer (CTO) at Bedfont® Scientific Limited, has been recognised for his outstanding contribution to innovation and technology. Scott has spent an impressive 18 years...

Written by Melissa Dooley, GastroLife This article reflects the opinions of a healthcare professional. The views expressed are their own. The intended use for the GastroCH4ECK® is to aid in the diagnosis of the following disorders: Lactose Intolerance, Small Intestinal...